Enhertu is a combination of a chemotherapy drug and targeted therapy. This type of therapy differs from immunotherapy.
Doctors prescribe Enhertu for certain types of breast, lung, and other cancers in adults. In this article, you can learn more about Enhertu’s goals and how it works. You can also find out how it differs from immunotherapy.
Enhertu is a combination of a chemotherapy drug and
Enhertu’s parts and active ingredients are:
- An antibody (with the ingredient fam-trastuzumab): This part of the drug targets and attaches to human epidermal growth factor receptor 2 (HER2) on cancer cells. (HER2 is a protein that may be found in higher amounts in some cancers.)
- Chemotherapy (with the ingredient deruxtecan-nxki): This part of the drug hinders and helps destroy cancer cells.

The goal of treatment with chemo is to cure the disease, if possible, or to control the disease by shrinking tumors and stopping the growth and spread of cancer. Chemo also provides palliation, which means it helps ease symptoms of cancer.
Various types of immunotherapy help treat cancer. Their goals vary somewhat, but all types generally help your immune system by identifying and attacking cancer cells. Each specific therapy has a unique way to accomplish this.
Doctors may prescribe other forms of treatment besides chemo and immunotherapy for some cancers.
Chemo and immunotherapy might be given the same way, depending on the therapy and the drug your doctor prescribes. You may
- by intravenous (IV) infusion (an injection into your vein over a period of time)
- by injection under your skin or injection into your muscle
- orally (by mouth)
- topically (by applying it to your skin)
You receive Enhertu by IV infusion. You may receive other drugs along with it to help prevent side effects.
Doctors prescribe Enhertu to treat certain types of breast, lung, and other cancers in adults. For a doctor to prescribe Enhertu, the cancer must involve HER2 in some way. Each of these cancers also has other specific criteria for treatment with Enhertu, including prior treatments received.
In brief, the cancers are:
- HER2-positive breast cancer
- unresectable or metastatic HER2-low breast cancer
- unresectable or metastatic non-small cell lung cancer with activating HER2 mutations (changes in HER2 that make the protein more active)
- locally advanced or metastatic HER2-positive gastric or gastroesophageal junction adenocarcinoma
- unresectable or metastatic HER2-positive solid tumors
“Unresectable” means the cancer cannot be removed with surgery. “Metastatic” means the cancer has spread from where it started to other parts of your body. “Locally advanced” means the cancer has grown beyond where it started but has not spread to other parts of your body.
Enhertu is a combination of a chemo drug and
Disclaimer: Healthline has made every effort to make certain that all information is factually correct, comprehensive, and up to date. However, this article should not be used as a substitute for the knowledge and expertise of a licensed healthcare professional. You should always consult your doctor or another healthcare professional before taking any medication. The drug information contained herein is subject to change and is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. The absence of warnings or other information for a given drug does not indicate that the drug or drug combination is safe, effective, or appropriate for all patients or all specific uses.